Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.

Samuel M Lindner Christopher B Fordyce Anne S Hellkamp Yuliya Lokhnygina Jonathan P Piccini Günter Breithardt Kenneth W Mahaffey Daniel E Singer Werner Hacke Jonathan L Halperin Graeme J Hankey Scott D Berkowitz Christopher C Nessel Richard C Becker Keith A A Fox Manesh R Patel

Circulation

From Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (S.M.L., C.B.F., A.S.H., Y.L., J.P.P., M.R.P.); Division of Cardiology, University of British Columbia, Vancouver, Canada (C.B.F.); Department of Cardiovascular Medicine, University of Münster, Germany (G.B.); Stanford University School of Medicine, CA (K.W.M.); Massachusetts General Hospital and Harvard Medical School, Boston (D.E.S.); Ruprecht-Karls-University, Heidelberg, Germany (W.H.); Cardiovascular Institute, Mount Sinai Medical Center, NY (J.L.H.); School of Medicine and Pharmacology, The University of Western Australia, Crawley (G.J.H.); Bayer HealthCare Pharmaceuticals, Parsippany, NJ (S.D.B.); Janssen Research and Development LLC, Raritan, NJ (C.C.N.); University of Cincinnati College of Medicine, OH (R.C.B.); and University of Edinburgh and Royal Infirmary of Edinburgh, UK (K.A.A.F.).

Published: March 2017

Download full-text PDF	Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024666	DOI Listing

Publication Analysis

Top Keywords

treatment consistency

consistency levels

levels baseline

baseline renal

renal function

function rivaroxaban

rivaroxaban warfarin

warfarin rocket

rocket rivaroxaban

rivaroxaban once-daily

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!